The North East Treatment Advisory Group. Anti-vascular endothelial growth factor therapies (bevacizumab and ranibizumab) in the management of macular oedema secondary to retinal vein occlusions. Empfehlungen und Studie des National Health System von Großbritannien - Horsley, W
Stand: Januar 2011